ResMed Cash End of Year Trend |
ResMed -- USA Stock | USD 100.19 0.98 0.97% |
This module enables investors to look at ResMed various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as Consolidated Income of 414.6 M, Cost of Revenue of 908.5 M or Earning Before Interest and Taxes EBIT of 530.3 M, but also many exotic indicators such as Long Term Debt to Equity of 0.6074, Calculated Tax Rate of 23.327 or PPandE Turnover of 5.5886. This module is a perfect complement to use when analyzing ResMed Valuation or Volatility. It can also complement various ResMed Technical models. Additionally take a look at analysis of ResMed Correlation with competitors.
Showing smoothed Cash End of Year of ResMed with missing and latest data points interpolated.
Cash End of Year | 10 Years Trend |
| Compare to Other EquitiesAll Fundamental Data |
Regression Statistics
Arithmetic Mean | 660,149,507 |
Geometric Mean | 618,003,245 |
Coefficient Of Variation | 32.71 |
Mean Deviation | 178,046,466 |
Median | 731,434,000 |
Standard Deviation | 215,936,272 |
Range | 647,938,000 |
R Value | 0.76 |
R Squared | 0.59 |
Significance | 0.002316 |
Slope | 42,414,036 |
ResMed Cash End of Year Over Time
Other Fundumenentals
My Equities
My Current Equities and Potential Positions
View AllNext |
RMD - USA StockResMed |
Medical EquipmentFama & French Classification | |
Region | North America |
Exchange | New York Stock Exchange |
$100.19
Thematic Opportunities
Explore Investment Opportunities
Additionally take a look at analysis of ResMed Correlation with competitors. Please also try Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.